Webcast

7-13 of 76 Activities
Title
Availability
Format
Credits
Launch Date
Buttons
Buttons
On-Demand
Webcast
0.75
02/19/2025

Psoriasis Progress: Bridging Knowledge Gaps in Emerging Therapies for Clearer Futures

In this CME Outfitters Snack, expert faculty, including dermatologists, will address the educational needs of dermatology providers and other HCPs including improving their knowledge of the efficacy and safety data for novel and emerging therapies in PsO, discussing clinical experiences, current and late-breaking research, and how to integrate this data into their management of patients with PsO.

0.75
02/19/2025

Susan C. Taylor, MD

Susan C. Taylor, MD

Andrew F. Alexis, MD, MPH

Andrew F. Alexis, MD, MPH

Moderator

Buttons
On-Demand
Webcast
1
02/10/2025

Closing Gaps in Care for Short Bowel Syndrome in the Community Setting

In this CME Outfitters recorded Grand Rounds activity, expert faculty will guide participants through a discussion of the pathophysiology and associated complications of SBS, currently available and emerging SBS treatment strategies promoting enteral autonomy and reducing the need for PN, and how to develop interdisciplinary and interprofessional coordinated care plans for patients with SBS managed in the community setting.

1
02/10/2025

Anne Debra Feldman NP-C

Anne Debra Feldman NP-C

Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, FASPEN, CNSC, CPNS

Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, FASPEN, CNSC, CPNS

Buttons

IBD, IL-23, and Inflammation, Oh My! Following the Yellow Brick Road in Using IL-23 Targeted Therapies in Managing IBD

In this CME Outfitters recorded symposium, expert faculty will instruct learners on the role of pro-inflammatory cytokines in the pathogenesis of IBD. Learners will be guided on the role of the IL-23/Th17 inflammatory axis in IBD pathogenesis and how to appraise the clinical implications of anti-IL-23 agents used in the treatment of IBD. Faculty will model the development of individualized treatment plans for patients with IBD that are eligible for treatment with an IL-23-targeted agent.

1.5
02/10/2025

Uma Mahadevan, MD

Uma Mahadevan, MD

Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN

Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN

Corey A. Siegel, MD, MS

Corey A. Siegel, MD, MS

Moderator

Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE, FCCF

Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE, FCCF

Buttons
On-Demand
Webcast
1
12/27/2024

Deciphering Ulcerative Colitis: Clinical Clues for Treatment Selection, Switching, and Disease Optimization

In this CME Outfitters Infographic, expert faculty will explore the role of new advanced therapies in UC treatment algorithms, facilitating the transition to these therapies in patients with UC who are non-/under-responsive to traditional treatments, and utilizing traditional treatments as well as available biologics and small-molecule therapies to optimize outcomes in patients with IP.

1
12/27/2024

Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Buttons
On-Demand
Webcast
1.5
12/20/2024

Bridging Gaps and Advancing Care in Sickle Cell Disease in the Context of Drug Therapy

In this CME Outfitters recorded webcast, expert faculty will elucidate the importance of comprehensive therapeutic and supportive care in preventing end-organ damage and improving QoL in patients with SCD. Learners will be guided through determining the effectiveness and challenges of current therapies to address the burden of disease in patients with SCD. Faculty will discuss emerging options in SCD treatment, including the long-term efficacy and safety of new interventions and investigational agents.

1.5
12/20/2024

Laura M. De Castro, MD, MHSc

Laura M. De Castro, MD, MHSc

Santosh L. Saraf, MD

Santosh L. Saraf, MD

Moderator

Maya Bloomberg, MSN, APRN

Maya Bloomberg, MSN, APRN

Buttons

Diagnostic and Therapeutic Advances in Primary Biliary Cholangitis: Maximizing Opportunities to Improve Patient Care and Outcomes

In this CME Outfitters recorded webcast, expert faculty will assess the burden of delayed diagnosis on patients with PBC, review evidence-based strategies for early, non-invasive detection, and discuss contemporary clinical pathways for treatment, including recent FDA-approved options. The program will also emphasize interdisciplinary collaboration and shared decision-making to empower patients and improve health outcomes through informed and equitable care. Learners will be equipped with evidence-based tools to help incorporate diagnostic and treatment approaches at the point of care. 

1
12/09/2024

Maria Morais, RN

Maria Morais, RN

K. Tuesday Werner, DNP, AGACNP, FNP-BC, AF-AASLD

K. Tuesday Werner, DNP, AGACNP, FNP-BC, AF-AASLD

Aliya Gulamhusein, MD, MPH, FRCPC

Aliya Gulamhusein, MD, MPH, FRCPC

Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD

Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD

Moderator